228 related articles for article (PubMed ID: 28886462)
21. Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1.
Hussin A; Md Nor NS; Ibrahim N
Antiviral Res; 2013 Nov; 100(2):306-13. PubMed ID: 24055837
[TBL] [Abstract][Full Text] [Related]
22. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.
Sauerbrei A; Bohn-Wippert K; Kaspar M; Krumbholz A; Karrasch M; Zell R
J Antimicrob Chemother; 2016 Jan; 71(1):6-16. PubMed ID: 26433780
[TBL] [Abstract][Full Text] [Related]
23. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
Biron KK; Fyfe JA; Noblin JE; Elion GB
Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
[TBL] [Abstract][Full Text] [Related]
24. Testing of herpes simplex virus for resistance to antiviral drugs.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Virulence; 2010; 1(6):555-7. PubMed ID: 21178503
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir.
Kamiyama T; Kurokawa M; Shiraki K
J Gen Virol; 2001 Nov; 82(Pt 11):2761-2765. PubMed ID: 11602787
[TBL] [Abstract][Full Text] [Related]
26. Variant Analysis of the Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus in Korea: Frequency of Acyclovir Resistance Mutations.
Hyun J; Lee SK; Kim JH; Cho EJ; Kim HS; Kim JS; Song W; Kim HS
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632051
[TBL] [Abstract][Full Text] [Related]
27. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
Yokota T; Konno K; Shigeta S; De Clercq E
Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
[TBL] [Abstract][Full Text] [Related]
28. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
29. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction.
Lacey SF; Suzutani T; Powell KL; Purifoy DJ; Honess RW
J Gen Virol; 1991 Mar; 72 ( Pt 3)():623-30. PubMed ID: 1848597
[TBL] [Abstract][Full Text] [Related]
30. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.
Suzutani T; Saijo M; Nagamine M; Ogasawara M; Azuma M
J Clin Microbiol; 2000 May; 38(5):1839-44. PubMed ID: 10790110
[TBL] [Abstract][Full Text] [Related]
31. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir-resistant varicella-zoster virus keratitis in an immunocompetent patient.
Gueudry J; Boutolleau D; Gueudin M; Burrel S; Miri A; Bodaghi B; Muraine M
J Clin Virol; 2013 Sep; 58(1):318-20. PubMed ID: 23756055
[TBL] [Abstract][Full Text] [Related]
33. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
[TBL] [Abstract][Full Text] [Related]
34. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus.
Suzutani T; Lacey SF; Powell KL; Purifoy DJ; Honess RW
J Virol; 1992 Apr; 66(4):2118-24. PubMed ID: 1312622
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
Bleymehl K; Cinatl J; Schmidt-Chanasit J
Med Microbiol Immunol; 2011 Aug; 200(3):193-202. PubMed ID: 21373931
[TBL] [Abstract][Full Text] [Related]
36. A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame.
Sahli R; Andrei G; Estrade C; Snoeck R; Meylan PR
Antimicrob Agents Chemother; 2000 Apr; 44(4):873-8. PubMed ID: 10722484
[TBL] [Abstract][Full Text] [Related]
37. Genotyping of varicella-zoster virus (vzv) wild-type strains isolated in the Czech Republic.
Bostikova V; Salavec M; Smetana J; Chlibek R; Kosina P; Prasil P; Plisek S; Splino M; Bostik P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):379-84. PubMed ID: 22336652
[TBL] [Abstract][Full Text] [Related]
38. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
[TBL] [Abstract][Full Text] [Related]
39. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management.
Piret J; Boivin G
Curr Opin Infect Dis; 2016 Dec; 29(6):654-662. PubMed ID: 27306564
[TBL] [Abstract][Full Text] [Related]
40. Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance.
Sauerbrei A; Liermann K; Bohn K; Henke A; Zell R; Gronowitz S; Wutzler P
Antiviral Res; 2012 Nov; 96(2):105-7. PubMed ID: 22906425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
